DEXCOM, INC. Stock Issued During Period, Value, Employee Stock Purchase Plan
New shares the company issued (share-based compensation, option exercises, employee stock purchase plans, new issues, acquisitions), as filed in its 10-Q and 10-K XBRL statement of shareholders' equity. This is the dilution side; Issuer Repurchases is the other side.
- DEXCOM, INC. stock issued during period, value, employee stock purchase plan for the quarter ending 2026-06-30 was $0.00.
- DEXCOM, INC. stock issued during period, value, employee stock purchase plan for the quarter ending 2026-03-31 was $12.70M, a 10.56% decline year-over-year.
- DEXCOM, INC. stock issued during period, value, employee stock purchase plan for the quarter ending 2025-12-31 was $0.00.
- DEXCOM, INC. stock issued during period, value, employee stock purchase plan for the quarter ending 2025-09-30 was $13.90M, a 6.08% decline year-over-year.
- DEXCOM, INC. stock issued during period, value, employee stock purchase plan for fiscal 2025 was $28.10M, a 0.35% decline from fiscal 2024.
- DEXCOM, INC. stock issued during period, value, employee stock purchase plan for fiscal 2024 was $28.20M, a 6.02% increase from fiscal 2023.
- DEXCOM, INC. stock issued during period, value, employee stock purchase plan for fiscal 2023 was $26.60M, a 18.22% increase from fiscal 2022.
- DEXCOM, INC. stock issued during period, value, employee stock purchase plan for fiscal 2022 was $22.50M, a 10.84% increase from fiscal 2021.
| Period end | Stock Issued During Period, Value, Employee Stock Purchase Plan 3 month | Stock Issued During Period, Value, Employee Stock Purchase Plan 12 month |
|---|---|---|
| 2026-06-30 | $0.00 derived: 10-Q 6 month − 10-Q 3 month · filed 2026-07-30 | $26.60M derived: sum of 4 quarters · filed 2026-07-30 |
| 2026-03-31 | $12.70M 10-Q · filed 2026-04-30 | $26.60M derived: sum of 4 quarters · filed 2026-07-30 |
| 2025-12-31 | $0.00 derived: 10-K 12 month − 10-Q 9 month · filed 2026-02-12 | $28.10M 10-K · filed 2026-02-12 |
| 2025-09-30 | $13.90M 10-Q · filed 2025-10-30 | $28.10M derived: sum of 4 quarters · filed 2026-07-30 |
| 2025-06-30 | $0.00 derived: 10-Q 6 month − 10-Q 3 month · filed 2026-07-30 | $29.00M derived: sum of 4 quarters · filed 2026-07-30 |
| 2025-03-31 | $14.20M 10-Q · filed 2026-04-30 | $29.00M derived: sum of 4 quarters · filed 2026-04-30 |
| 2024-12-31 | $0.00 derived: 10-K 12 month − 10-Q 9 month · filed 2026-02-12 | $28.20M 10-K · filed 2026-02-12 |
| 2024-09-30 | $14.80M 10-Q · filed 2025-10-30 | $28.20M derived: sum of 4 quarters · filed 2026-02-12 |
| 2024-06-30 | $0.00 derived: 10-Q 6 month − 10-Q 3 month · filed 2025-07-30 | $27.70M derived: sum of 4 quarters · filed 2026-02-12 |
| 2024-03-31 | $13.40M 10-Q · filed 2025-05-01 | $27.70M derived: sum of 4 quarters · filed 2026-02-12 |
| 2023-12-31 | $0.00 derived: 10-K 12 month − 10-Q 9 month · filed 2026-02-12 | $26.60M 10-K · filed 2026-02-12 |
| 2023-09-30 | $14.30M 10-Q · filed 2024-10-24 | $26.60M derived: sum of 4 quarters · filed 2025-02-18 |
| 2023-06-30 | $0.00 derived: 10-Q 6 month − 10-Q 3 month · filed 2024-07-25 | $24.70M derived: sum of 4 quarters · filed 2025-02-18 |
| 2023-03-31 | $12.30M 10-Q · filed 2024-04-25 | $24.70M derived: sum of 4 quarters · filed 2025-02-18 |
| 2022-12-31 | $0.00 derived: 10-K 12 month − 10-Q 9 month · filed 2025-02-18 | $22.50M 10-K · filed 2025-02-18 |
| 2022-09-30 | $12.40M 10-Q · filed 2023-10-26 | $22.50M derived: sum of 4 quarters · filed 2024-02-08 |
| 2022-06-30 | $0.00 derived: 10-Q 6 month − 10-Q 3 month · filed 2023-07-27 | $21.70M derived: sum of 4 quarters · filed 2024-02-08 |
| 2022-03-31 | $10.10M 10-Q · filed 2023-04-27 | $21.70M derived: sum of 4 quarters · filed 2024-02-08 |
| 2021-12-31 | $0.00 derived: 10-K 12 month − 10-Q 9 month · filed 2024-02-08 | $20.30M 10-K · filed 2024-02-08 |
| 2021-09-30 | $11.60M 10-Q · filed 2022-10-27 | $20.30M derived: sum of 4 quarters · filed 2023-02-09 |
| 2021-06-30 | $0.00 10-Q · filed 2021-07-29 | $17.30M derived: sum of 4 quarters · filed 2023-02-09 |
| 2021-03-31 | $8.70M 10-Q · filed 2022-04-28 | $17.30M derived: sum of 4 quarters · filed 2023-02-09 |
| 2020-12-31 | $0.00 derived: 10-K 12 month − 10-Q 9 month · filed 2023-02-09 | $15.00M 10-K · filed 2023-02-09 |
| 2020-09-30 | $8.60M 10-Q · filed 2021-10-28 | $15.00M derived: sum of 4 quarters · filed 2022-02-14 |
| 2020-06-30 | $0.00 10-Q · filed 2021-07-29 | $13.20M derived: sum of 4 quarters · filed 2022-02-14 |
| 2020-03-31 | $6.40M 10-Q · filed 2021-04-29 | $13.20M derived: sum of 4 quarters · filed 2022-02-14 |
| 2019-12-31 | $0.00 derived: 10-K 12 month − 10-Q 9 month · filed 2022-02-14 | $11.60M 10-K · filed 2022-02-14 |
| 2019-09-30 | $6.80M 10-Q · filed 2020-10-27 | $11.60M derived: sum of 4 quarters · filed 2021-02-11 |
| 2019-06-30 | $0.00 10-Q · filed 2019-07-31 | $9.60M derived: sum of 4 quarters · filed 2021-02-11 |
| 2019-03-31 | $4.80M 10-Q · filed 2020-04-28 | $9.60M derived: sum of 4 quarters · filed 2021-02-11 |
| 2018-12-31 | $0.00 derived: 10-K 12 month − 10-Q 9 month · filed 2021-02-11 | $8.90M 10-K · filed 2021-02-11 |
| 2018-09-30 | $4.80M 10-Q · filed 2019-11-06 | |
| 2018-06-30 | $0.00 10-Q · filed 2019-07-31 | |
| 2018-03-31 | $4.10M 10-Q · filed 2019-05-01 | |
| 2017-12-31 | $7.40M 10-K · filed 2020-02-13 | |
| 2016-12-31 | $6.00M 10-K · filed 2019-02-21 | |
| 2015-12-31 | $3.80M 10-K · filed 2018-02-27 | |
| 2014-12-31 | $2.60M 10-K · filed 2017-02-28 | |
| 2013-12-31 | $1.90M 10-K · filed 2016-02-23 | |
| 2012-12-31 | $1.50M 10-K · filed 2015-02-25 | |
| 2011-12-31 | $1.30M 10-K · filed 2014-02-20 | |
| 2010-12-31 | $900.00K 10-K · filed 2013-02-21 | |
| 2009-12-31 | $541.00K 10-K · filed 2012-02-23 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| WEST PHARMACEUTICAL SERVICES INC (WST) | United States | $26.288B | 43.14 |
| BECTON DICKINSON & CO (BDX) | United States | $48.834B | 43.79 |
| Solventum Corp (SOLV) | United States | $15.085B | 9.16 |
| Penumbra Inc (PEN) | United States | $12.596B | 77.33 |
| BAXTER INTERNATIONAL INC (BAX) | United States | $12.139B | -10.35 |
| GLOBUS MEDICAL INC (GMED) | United States | $9.977B | 20.03 |
| INSULET CORP (PODD) | United States | $9.420B | 28.12 |
| GLAUKOS Corp (GKOS) | United States | $9.135B | -43.73 |
| MiniMed Group, Inc. (MMED) | United States | $5.748B | -16.85 |
| MERIT MEDICAL SYSTEMS INC (MMSI) | United States | $5.212B | 28.44 |